The UK-licensed digital bank Revolut is planning a secondary share sale valuing it at $115 billion, following regulatory milestones including a UK banking license and US charter application.
Revolut is moving forward with a secondary share offering that would value the fintech at $115 billion, sources told Bloomberg. The secondary sale comes as the company has achieved key regulatory checkpoints in major markets.
The digital bank recently secured a UK banking license, a significant milestone that allows it to operate as a full bank in Britain. Simultaneously, Revolut has applied for a charter in the United States, signaling its intent to expand regulated operations across the Atlantic.
The $115 billion valuation represents substantial growth for the London-based fintech since its 2015 founding. Secondary share sales allow existing shareholders to sell their stakes without diluting the company through new equity issuance, making them common among mature private companies or those preparing for eventual public markets entry.
Revolut has expanded significantly across Europe and Asia, offering services ranging from payments and money transfers to cryptocurrency trading and investment products. The company has faced regulatory scrutiny in various jurisdictions but has worked to bring its operations into compliance with banking standards.
The timing of the secondary sale suggests investor confidence in Revolut's regulatory trajectory. UK banking status provides credibility for serving consumers and businesses in one of Europe's largest financial markets. The US charter application, if approved, would open access to the American market—a major growth opportunity for fintech firms.
Secondary transactions at this valuation level typically involve large institutional investors and existing backers. Previous Revolut investors include SoftBank, Tiger Global, and various venture capital firms.
No public timeline has been announced for the secondary sale or the status of the US charter application. The company has not commented on the Bloomberg report.
Scan.com, an AI-powered platform that matches patient referrals with imaging centers based on availability, price, and specialty, closed a $220M Series C round. The funding comprises $90M in equity and $130M in debt facilities.
Robot data startup XDOF, which exited stealth three months ago, is in talks to raise a Series B round at a $1.2 billion valuation. The funding marks a rapid scaling trajectory for the early-stage company.
AI compute provider Nscale is pursuing $3.5 billion in pre-IPO financing as it prepares for a public market debut. The funding push follows the company's recent $45 billion deal with AI safety firm Anthropic.